Blood test could predict prostate cancer drug success
Knowledge-focused
Terminated
This study aimed to see if measuring a specific protein in the blood (called uPAR) could help predict which men with advanced prostate cancer would respond well to the drug abiraterone. It involved a very small group of patients whose cancer had progressed despite other treatment…
Sponsor: Kristoffer Rohrberg • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:03 UTC